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Objectives: The purpose of this study was to evaluate the exposure to arsenic in preventive maintenance (PM)
engineers in a semiconductor industry by detecting speciated inorganic arsenic metabolites in the urine.
Methods: The exposed group included 8 PM engineers from the clean process area and 13 PM engineers from the
ion implantation process area; the non-exposed group consisted of 14 office workers from another company who
were not occupationally exposed to arsenic. A spot urine specimen was collected from each participant for the
detection and measurement of speciated inorganic arsenic metabolites. Metabolites were separated by high
performance liquid chromatography-inductively coupled plasma spectrometry-mass spectrometry.
Results: Urinary arsenic metabolite concentrations were 1.73 g/L, 0.76 g/L, 3.45 g/L, 43.65 g/L, and 51.32 g/L for
trivalent arsenic (As3+), pentavalent arsenic (As5+), monomethylarsonic acid (MMA), dimethylarsinic acid (DMA), and
total inorganic arsenic metabolites (As3+ + As5+ + MMA + DMA), respectively, in clean process PM engineers. In ion
implantation process PM engineers, the concentrations were 1.74 g/L, 0.39 g/L, 3.08 g/L, 23.17 g/L, 28.92 g/L for
As3+, As5+, MMA, DMA, and total inorganic arsenic metabolites, respectively. Levels of urinary As3+, As5+, MMA, and
total inorganic arsenic metabolites in clean process PM engineers were significantly higher than that in the non-
exposed group. Urinary As3+ and As5+ levels in ion implantation process PM engineers were significantly higher
than that in non-exposed group.
Conclusion: Levels of urinary arsenic metabolites in PM engineers from the clean process and ion implantation
process areas were higher than that in office workers. For a complete assessment of arsenic exposure in the
semiconductor industry, further studies are needed.
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The production of semiconductors continues to increase,
as semiconductors are essential in the manufacturing of
electronics. In Korea, the semiconductor industry has
grown rapidly over the last decade, and semiconductors
produced in Korea comprise a large share of the world
market. Semiconductor manufacturing requires some* Correspondence: toxneuro@kosha.net
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stated.toxic materials, which poses a risk of exposure to workers
in the industry. The semiconductor production process
can be divided into 2 sequential sub processes: wafer fabri-
cation and chip assembly.
The wafer fabrication process is a multiple-step se-
quence of photolithographic and chemical processing
steps including diffusion, photolithography, etching, ion
implant, and metal deposition, during which electronic
circuits are created on a wafer. During the diffusion
process, dopants diffuse and an oxide film is formed on
the wafer. In the photolithography process, the circuit
pattern is formed. In the etching process, unnecessaryd. This is an Open Access article distributed under the terms of the Creative
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process, impurities such as arsenic or phosphorus ions
are implanted in order to impart conductivity to the
wafer. Finally, in the metal deposition process, the parts
of the circuits are connected electrically by depositing a
conductive metal on the silicon wafer to create the inte-
grated circuits [1]. Arsine is widely used in the wafer
manufacturing process, especially during ion implant-
ation, to impart conductivity to the wafer. Because of
this, workers in the ion implantation process can be ex-
posed to arsenic from arsine [2,3].
Before and after each step of wafer fabrication, there is
another step called clean process where the wafers are
cleaned using a solution of hydrofluoric acid, sulfuric
acid, phosphoric acid, hydrogen peroxide, nitric acid, or
isopropyl alcohol. During the clean process after ion im-
plantation, arsenic ion can be dissolved in the cleaning
solution. Therefore, workers of the clean process can
also be exposed to arsenic.
Usually, workers in semiconductor manufacturing are
categorized into operators and preventive maintenance
(PM) engineers. The operators, who handle the wafers,
are exposed to relatively low concentrations of chemicals.
The PM Engineers are responsible for the processes and
the equipment; hence, they frequently take apart the
equipment and clean the inner parts. Thus, they are likely
to be exposed to high concentrations of the various
chemicals [4].
Arsenic is abundant on the earth, but exposure to ar-
senic has adverse health effects. Acute arsenic toxicity
affects many organ systems including the gastrointes-
tinal, dermal, nervous, hematopoietic, and cardiovascular
systems. Long-term exposure to non-lethal doses of ar-
senic has been found to induce peripheral neuropathy,
anemia, cardiac and peripheral vascular disease, anemia,
hyperkeratosis, and hyperpigmentation of the skin [5].
Inorganic arsenic induces cancer of the skin, liver, and
lung [6]. Arsenic compounds may be absorbed after in-
gestion, inhalation, or skin contact and are excreted in
the urine.
In the blood, pentavalent arsenate (As5+) can be re-
duced to trivalent arsenite (As3+) in the blood, which is
taken up mainly by the liver [7]. As3+ is metabolized to
monomethylarsonic acid (MMA) and dimethylarsinic
acid (DMA) by oxidative methylation and reduction. In
humans, these metabolic processes do not go to comple-
tion, and inorganic arsenic along with mono- and di-
methylated metabolites are excreted in the urine [8].
The measurement of urinary arsenic levels is generally
accepted as the most reliable indicator of recent arsenic
exposure [9].
Arsenic is naturally present in water, soil, and food,
and seafood contains high levels of organoarsenic com-
pounds such as arsenobetaine and arsenocholine thatare less toxicity to humans. These organoarsenic com-
pounds usually do not interfere with the metabolism of
inorganic arsenic [10,11]. However, if total arsenic in
the urine is measured, intakes of arsenobetaine and
arsenocholine from seafood will interfere with the de-
tection of occupational exposure to inorganic arsenic.
To prevent interference from arsenic of marine origin,
urinary arsenic speciation analysis, which can separately
measure inorganic arsenic and its main urinary metabo-
lites, is used [12,13].
There have been several studies on the exposure of
workers to toxic factors in the semiconductor manufac-
turing industries in Korea [14], but real time assessment
of arsenic exposure among PM engineers of the ion im-
plantation process, and especially of the clean process,
has not yet been reported. A few studies have assessed
arsenic exposure using urinary speciated arsenic metabo-
lites in workers in the ion implantation process in the
United States [15], the United Kingdom, [16] and Taiwan
[17]. However, these studies did not examine workers of
the clean process. In Korea, exposure of workers in semi-
conductor manufacturing industries to arsenic has not
previously been studied using the measurement of urinary
speciated arsenic metabolites as an index of biological ex-
posure. In this study, to examine exposure to arsenic
among workers of the semiconductor manufacturing
process, we measured urinary speciated arsenic metabo-




To evaluate the level of arsenic exposure relatively, we se-
lected exposed group and non-exposed group. Partici-
pants were recruited from workers at a semiconductor
manufacturing company. All of the PM engineers from
the clean process and ion implantation process areas (n =
8 and n = 14, respectively), except night shift workers and
off-duty workers, participated in this study. The non-
exposed group consisted of 14 office workers from an-
other company who were not occupationally exposed to
arsenic. Duty of the PM engineers of clean process was
checking the equipment of the clean process where the
wafers are cleaned before and after each step of wafer fab-
rication such as photolithography process or ion implant-
ation process. PM engineers of ion implantation process
did the similar job on the ion implantation equipment. All
participants were men. Preliminary explanation for this
study was presented to all the participants. Only workers
who signed informed consent documents participated in
the study. The participants were interviewed and data on
smoking status, consumption of seafood (fish, seaweed,
shellfish, and crustaceans) during the previous 3 days, and
job description were recorded. At the end of a working
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from each participant.Urinary arsenic analysis using high performance liquid
chromatography-inductively coupled plasma mass
spectrometry (HPLC-ICP-MS)
A blank specimen, standard material for a calibration
curve, and urine specimens for analysis (worker and qual-
ity control [QC] specimens, diluted 3:1 in 1% nitric acid)
were placed in ICP-MS vials, after filtering through a cel-
lulose acetate (0.2 m) filter. Filtered specimens were ana-
lyzed by HPLC-ICP-MS (ELAN DRC-II, Perkin Elmer,
USA) (Table 1). We used G-EQUAS, the German External
Quality Assessment Scheme, with the G-EQUAS 50 refer-
ence values, to standardize our analyses. We measured
each specimen 7 times (same medium, same concentra-
tion) and calculated the standard deviation. We multiplied
the standard deviation by 3 to determine the method
detection limit (MDL). The MDLs were 0.148 g/L,
0.197 g/L, 0.137 g/L, and 0.054 g/L for As3+, As5+,
MMA, and DMA, respectively. In the analysis of urinary
speciated arsenic metabolites from the study participants,
there were 5 cases with As5+ below 0.197 g/L, which is the
MDL. In 6 cases where the metabolite was not detected
(ND), a value of half the MDL was assigned.Table 1 Operating conditions for the HPLC and ICP-
DRC-MS
High-performance liquid chromatography
Solvent A 6 mM Ammonium cabonate
Solvent 20 mM Ammonium phosphate, monobasic
Flow Rate 1.2 mL/min
Column Anion Exchange, Hamilton PRP-X100,
4.6 mm I.d. × 150 mm, 5 μm
Guard column 2.3 × 30 mm PRP-X100TM
Autosampler flush solvent 5% Methanol
Sample injection volume 50 μL
Inductively coupled plasma- dynamic Reaction Cell- mass
spectrometry (ICP-DRC-MS)
RF Power 1400 W





Dwell time 250 ms
Cell gas High purity O2 Gas
Cell gas flow rate 0.50 mL/min
RPQ 0.45Statistical analysis
Student’s t tests were performed to compare the concen-
trations of urinary speciated inorganic arsenic metabo-
lites by smoking status and seafood intake. An ANOVA
was conducted to compare the concentrations of urinary
speciated inorganic arsenic metabolites among the 3
groups (PM engineers from the clean process area, PM
engineers from the ion implantation process area, and
office workers). Urinary speciated inorganic arsenic me-
tabolites were transformed to a logarithmic scale. Mul-
tiple regression analysis was conducted with the groups
(clean process, ion implantation process, office work) as
independent variables with adjustment for the effects of
smoking and recent seafood consumption, which are
well-known confounders of urinary arsenic values from
occupational exposure. A p value of <0.05 was consid-
ered significant. Statistical analyses were conducted
using SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Among the 35 study participants, 75% of clean process
PM engineers (6 of 8), 38.46% of ion implantation PM
engineers (5 of 13), and 35.71% of the non-exposed
group (5 of 14) were current smokers. Five clean process
PM engineers had consumed seafood during last 3 days,
and 2 clean process PM engineers and 6 office workers
had ever had seafood. Neither smoking nor seafood con-
sumption had a significant effect on the level of urinary
speciated inorganic arsenic metabolites (As3+, As5+,
MMA, and DMA). It shows no statistical significant dif-
ferences on speciated urinary inorganic arsenic metabo-
lites (As3+, As5+, MMA, and DMA) among each group
(Table 2).
The results of the analysis of urinary speciated arsenic
metabolite values are shown in Table 3, which gives the
geometric means (GM) of the concentrations of As3+,
As5+, MMA, and DMA for each group. The geometric
mean of As3+ of clean process PM, ion implantation
PM and office workers were 1.73 μg/L, 1.74 μg/L, and
0.95 μg/L, respectively, which showed significant differ-
ence (p < 0.05). The geometric mean of As5+ for clean
process PM, ion implantation PM and office workers
were 0.76 μg/L, 0.39 μg/L, 0.18 μg/L, respectively, which
also showed significant difference (p < 0.05). MMA
values showed a similar trend, i.e., 3.45 μg/L, 3.08 μg/L
and 2.310 μg/L for clean process PM, ion implantation
PM and office workers, respectively (p < 0.05). As3+ and
As5+ value, summed up to represent inorganic arsenic
level, were 2.58 μg/L, 2.23 μg/L and 1.17 μg/L for clean
process PM, ion implantation PM and office workers, re-
spectively, which shows significant difference (p < 0.05).
Summed value of inorganic arsenic and MMA were
6.11 μg/L, 5.34 μg/L and 3.37 μg/L for clean process PM,
ion implantation PM and office workers, respectively
Table 2 The concentrations of urinary speciated inorganic arsenic metabolites by smoking status and seafood intake
As3+ As5+ MMA DMA As3++ As5+ As3++ As5++MMA As3++ As5++MMA + DMA
No smoking AM 1.67 0.58 2.96 33.72 2.25 5.21 38.93
(N = 22) GM 1.33 0.37 2.62 26.92 1.80 4.51 32.48
GSD 1.90 2.74 1.71 2.05 1.92 1.74 1.91
Med 1.17 0.45 2.89 29.45 1.53 4.57 33.85
Min 0.62 0.10 0.62 6.30 0.72 1.33 8.22
Max 6.51 2.52 6.50 88.30 7.80 14.30 93.15
Smoking AM 1.56 0.37 3.13 32.94 1.94 5.07 38.01
(N = 13) GM 1.70 0.27 2.85 26.86 1.76 4.69 32.12
GSD 1.62 2.38 1.59 2.00 1.64 1.52 1.88
Med 1.70 0.35 2.59 29.62 2.21 4.67 36.93
Min 0.55 0.10 1.27 10.27 0.65 2.70 13.56
Max 2.49 0.94 5.37 69.39 2.83 7.94 74.07
P-value 0.75 0.40 0.63 0.99 0.92 0.83 0.96
No seafood AM 1.82 0.41 3.23 29.23 2.23 5.46 34.69
(N = 22) GM 1.50 0.29 2.93 23.98 1.87 4.89 29.41
GSD 1.83 2.40 1.59 1.95 1.78 1.61 1.85
Med 1.45 0.35 2.93 25.73 1.62 4.97 32.16
Min 0.65 0.10 1.08 6.30 0.84 1.92 8.22
Max 6.51 1.28 6.50 60.18 7.80 14.30 65.15
Seafood AM 1.30 0.66 2.68 40.54 1.96 4.64 45.18
(N = 13) GM 1.16 0.40 2.37 32.65 1.64 4.09 37.99
GSD 1.67 2.96 1.74 2.08 1.87 1.71 1.91
Med 1.14 0.50 2.48 39.31 1.94 4.07 40.65
Min 0.55 0.10 0.62 8.88 0.65 1.33 10.96
Max 2.62 2.52 5.37 88.30 5.14 9.53 93.15
P-value 0.20 0.33 0.23 0.21 0.52 0.31 0.25
As3+: trivalent arsenic, As5+: pentavalent arsenic, GM, Geometric mean; GSD, Geometric standard deviation; N, Number of subjects; MMA, Monomethylarsonic acid;
DMA, Dimethylarsinic acid, P-value: probability by t-test.
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insignificant (p 0.08). They were 43.65 μg/L, 23.17 μg/L
and 23.43 μg/L for clean process PM, ion implantation
PM and office workers, respectively. Total inorganic ar-
senic metabolites values, which is the summation of As3+,
As5+, MMA and DMA, were 52.32 μg/L, 28.92 μg/L and
27.57 μg/L for clean process PM, ion implantation PM
and office workers, respectively, which showed statistically
insignificant value (p 0.06). The GM of urinary As3+, As5+,
and MMA in the clean process PM engineers were the
highest, followed by that in the ion implantation PM engi-
neers and the non-exposed group. The GM of the sum of
DMA and inorganic arsenic metabolites was the highest
in clean process PM engineers, followed by that in the
non-exposed group and ion implantation PM engineers.
The result of the multiple regression analysis revealed
that the concentrations of As3+, As5+, MMA, the sum of
inorganic arsenic (i.e., As3+ + As5+), the sum of inor-
ganic arsenic and MMA, and the total inorganic arsenicmetabolites were higher in clean process PM engineers
than in non-exposed group. The concentrations of As3+,
As5+, the sum of inorganic arsenic (As3+ + As5+), and
the sum of inorganic arsenic and MMA were also higher
in ion implantation PM engineers than in the non-
exposed group (Table 4).
Discussion
The workers in semiconductor manufacturing plants can
be exposed to various toxic substances. Among them, the
arsenic used in the ion implantation process as arsine gas
is one of the most significant problems. In this study, mul-
tiple regression analysis revealed that As3+, As5+, the sum
of inorganic arsenic (As3++ As5+), and the sum of inor-
ganic arsenic and MMA were higher in ion implantation
PM engineers than in the non-exposed group.
Previous studies showed that PM engineers who han-
dle the normal processes of the fabrication operation are
exposed to arsenic levels that are substantially lower
Table 3 The concentrations of urinary speciated inorganic arsenic metabolites (in µg/L) by work group
As3+ As5+ MMA DMA As3++ As5+ As3++ As5++MMA As3++ As5++MMA + DMA
Clean AM 1.87 0.95 3.60 48.70 2.82 6.42 55.12
(N = 8) GM 1.73 0.76 3.45 43.65 2.58 6.11 51.32
GSD 1.54 1.99 1.38 1.72 1.57 1.42 1.52
Med 2.03 0.68 3.40 48.84 2.61 6.71 54.55
Min 0.83 0.34 1.94 14.07 1.17 3.11 23.60
Max 2.63 2.52 5.37 88.30 5.14 9.53 93.15
Ion implantation AM 1.88 0.48 3.26 27.23 2.36 5.62 32.85
(N = 13) GM 1.74 0.39 3.08 23.17 2.23 5.34 28.92
GSD 1.51 2.11 1.42 1.76 1.43 1.40 1.66
Med 1.86 0.50 2.96 19.94 2.30 5.51 25.86
Min 0.76 0.10 1.84 12.28 1.21 3.25 16.35
Max 4.09 0.94 5.37 69.39 4.53 9.89 74.07
Office AM 1.26 0.27 2.47 30.47 1.53 4.00 34.47
(N = 14) GM 0.95 0.18 2.10 23.43 1.17 3.37 27.57
GSD 1.86 2.36 1.83 2.22 1.82 1.74 2.08
Med 0.74 0.10 2.27 28.35 1.07 3.27 31.70
Min 0.55 0.10 0.62 6.30 0.65 1.33 8.22
Max 6.51 1.28 6.50 60.18 7.80 14.30 65.15
All AM 1.63 0.50 3.02 33.43 2.13 5.15 38.59
(N = 35) GM 1.36 0.33 2.71 26.90 1.78 4.58 32.35
GSD 1.79 2.60 1.65 2.01 1.80 1.65 1.88
Med 1.14 0.41 2.88 29.62 1.70 4.67 36.93
Min 0.55 0.10 0.62 6.30 0.65 1.33 8.22
Max 6.51 2.52 6.50 88.30 7.80 14.30 93.15
P-value <0.05 <0.05 <0.05 0.08 <0.05 <0.05 0.06
As3+: trivalent arsenic, As5+: pentavalent arsenic, GM, Geometric mean; GSD, Geometric standard deviation, N, Number of subjects; MMA, Monomethylarsonic acid;
DMA, Dimethylarsinic acid, P-value: probability by ANOVA test.
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ately maintained by engineering controls such as exhaust
ventilation, enclosure, and shielding of the operation
equipment [4]. However, the equipment, which is sealed
during normal operations, is opened and disassembled
by the PM engineers during the maintenance process;
hence, they can be exposed to residual arsenic that ad-
heres to the inner surfaces of the equipment [2,18]. In a
Taiwanese study that monitored arsenic exposure dur-
ing the maintenance of an ion implanter, arsenic levels
were very low in environmental samples, but were
much higher in some wipe samples, used cleaning
cloths, and gloves [2]. The results indicated that arsenic
intake via ingestion, rather than through inhalation,
might play a significant role in the elevation of urinary
arsenic levels of workers performing maintenance on an
ion implanter [2].
In another Taiwanese study that monitored arsenic ex-
posure in ion implanter PM engineers, the levels of total
urinary inorganic arsenic metabolites in PM engineerswere 1.7 g/L, 1.4 µg/L, 6.2 µg/L, 20.2 µg/L, 29.5 µg/L for
As3,+, As5+, MMA, DMA, and total urinary inorganic ar-
senic metabolites, respectively. Further, both the concen-
tration of MMA and its percentage of the total urinary
inorganic arsenic metabolites were significantly higher in
PM engineers than in the non-exposed group [17].
In the study of Hu et al. (2006) that evaluated the ef-
fects of arsenic exposure among semiconductor workers,
the mean urinary concentrations of As3+, As5+, MMA,
DMA, and total arsenic metabolites (the sum of As3+,
As5+, MMA and DMA) were 2.19 g/L, 0.82 g/L, 3.86 g/L,
44.33 g/L, and 51.21 g/L for exposed workers, respectively,
and exposed workers had significantly higher concentra-
tions of MMA, DMA, and total arsenic metabolites than
non-exposed workers [19]. In the Taiwanese studies
[17,19], the levels of urinary arsenic metabolites of the ex-
posed groups were similar to those of clean process PM
engineers in our study.
In a British study that monitored concentrations of urin-
ary arsenic compounds, the mean urinary concentrations
Table 4 Multiple regression analysis of inorganic arsenic metabolites by work group
Estimate Standard error P-value R2
As3+* Ion implantation 0.53 0.21 0.02
Clean 0.66 0.23 0.01
Office reference 0.31
As5+* Ion implantation 0.90 0.32 0.01
Clean 1.38 0.36 <0.01
Office reference 0.40
MMA* Ion implantation 0.30 0.19 0.12
Clean 0.56 0.21 0.01
Office reference 0.24
DMA* Ion implantation 0.03 0.27 0.92
Clean 0.60 0.31 0.06
Office reference 0.16
As3++ As5+* Ion implantation 0.61 0.20 0.01
Clean 0.82 0.23 <0.01
Office reference 0.37
As3++ As5++MMA* Ion implantation 0.40 0.18 0.03
Clean 0.64 0.20 <0.01
Office reference 0.31
As3++ As5++MMA+DMA* Ion implantation 0.08 0.25 0.75
Clean 0.60 0.28 0.04
Office reference 0.18
As3+: trivalent arsenic, As5+: pentavalent arsenic, GM, Geometric mean; GSD, Geometric standard deviation; MMA, Monomethylarsonic acid; DMA, Dimethylarsinic
acid, Total: sum of inorganic arsenic metabolites (As3++ As5++MMA +DMA), * adjusted for smoking status, seafood intake.
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(sum of As3+, As5+, MMA, and DMA) were 0.6 µg/L,
0.2 µg/L, 0.7 µg/L, 4.9 µg/L, and 6.4 µg/L, respectively, for
exposed workers in the semiconductor manufacturing in-
dustry [16]. These levels were lower than that in our study.
In our study, the levels of urinary arsenic metabolites
in clean process PM engineers were higher than those in
ion implantation process PM engineers and the non-
exposed group. In an experimental study conducted by
Ungers et al. (1985), silicon wafers were found to emit
inorganic arsenic following ion implantation. Data col-
lected during this experiment demonstrated that arsenic
is released over a 3.5-hour period following implant-
ation and that the total amount of arsenic emitted may
approach 6.0 g per 100 wafers processed within 4 hours
after implantation [3]. However, there is a lack of re-
search evaluating arsenic exposure for clean process
PM engineers.
Urinary arsenic is determined in a secondary con-
firmative test in special medical examinations in Korea,
with the limit being 220 g/L [20]. ACGIH recommends
total inorganic arsenic metabolites should not exceed
35 g/L as the biological exposure limit (BEL) [9]. An
upper limit for speciated arsenic metabolites in the urine
has not been established thus far in Korea. Our resultsshow that the levels of total inorganic metabolites in
88% of clean process PM engineers exceeded the BEL
set by ACGIH; further, the levels exceeded the BEL in
43% of the non-exposed group and 39% of the ion
implantation PM engineers. Several office workers of the
non-exposed group had levels that exceeded the BEL,
which can be attributed to non-occupational environ-
mental factors or diet, especially seafood intake. The
average seafood intake is much higher in Asian countries
such as Korea, Japan, and Taiwan, than in Europe or the
United States [21]. Likewise, the concentration of urin-
ary arsenic in the Asian population is higher than in
Western countries [22,23]. Because of the apparent cor-
relation between seafood intake and arsenic exposure,
the BEL should be applied in a conservative manner and
may not be suitable to assess health risks. A study of the
general population in Japan showed that the median
value of urinary inorganic arsenic metabolites (the sum
of As3+, As5+, MMA, and DMA) was 54 g/L, which
exceeded the BEL [22]. It is notable that certain arsenic
metabolites can be found even in the general population
in the absence of occupational arsenic exposure. Similar
research results in Korea revealed that the average con-
centration of urinary arsenic in the general population
was 118 μg/g creatinine [24], which is comparable to the
Byun et al. Annals of Occupational and Environmental Medicine 2013, 25:21 Page 7 of 8
http://www.aoemj.com/content/25/1/21level of 149 μg/g creatinine in Japanese study [25]; both
values are substantially higher than the average urinary
arsenic concentration in the general population of the
United States, which was 8.30 μg/L or 8.24 μg/g creatin-
ine [26].
Shellfish are rich in DMA, which when ingested is not
metabolized, but directly excreted in the urine [27].
Arsenosugars, which can be found in seaweed, mussels,
shellfish, and oysters, is metabolized to DMA in the hu-
man body and can be excreted in the urine [28]. One
study demonstrated increased total urinary inorganic
arsenic metabolites, especially DMA, in a group of vol-
unteers after consuming seaweed. Thus, urinary DMA
does not represent occupational exposure to arsenic, but
is a marker of seafood intake [29]. Hakala et al. (1995)
performed a study in copper smelter workers to assess
occupational arsenic exposure; they showed that urinary
inorganic arsenic (As3+, As5) is more useful for assessing
occupational exposure to arsenic, rather than total urin-
ary inorganic arsenic metabolites [30]. In this study, the
concentration of inorganic arsenic (As3+, As5) was signifi-
cantly different between groups. Because seafood con-
sumption in Asian countries is higher than in Western
countries, Hata et al. (1995), on the basis of their findings
in the general population in Japan, recommended exclud-
ing DMA when assessing occupational exposure to ar-
senic [22]. We analyzed the urinary inorganic arsenic
metabolites As3+, As5+, and MMA (excluding DMA), and
found a significant difference between the exposed and
the non-exposed groups. The DMA concentration, how-
ever, was not significantly different between groups, even
after adjusting for confounders such as smoking and sea-
food intake.
This study has certain limitations. First, the study
results are based on a single urine sample from each
participant; hence, we could not establish the reproduci-
bility and accuracy of the measurements. A second
limitation concerns control of the seafood intake. To ex-
clude the arsenic intake from seafood, we strongly
recommended participants to consume seafood for at
least 2 days, but it was not strictly followed. This might
have affected the interpretation of the levels of DMA. Fi-
nally, the non-exposed group should have been selected
from the same community or workplace to control for
environmental arsenic exposure (such as from water or
air pollution), but we could not find suitable candidates
among the workers’ colleagues.
This study aimed at assessing exposure to arsenic in
semiconductor manufacturing workers, specifically in
PM engineers of the clean process and the ion implant-
ation process areas using urinary inorganic arsenic me-
tabolite levels. Prior studies assessing arsenic exposure
in the semiconductor industry focused mainly on ion
implantation process workers, in whom the level isknown to be negligible [14]. In this study, however, urin-
ary inorganic arsenic metabolites in clean process and
ion implantation PM engineers were higher than in the
non-exposed group, after adjustment for smoking and
seafood intake. Urinary inorganic arsenic metabolites in
clean process PM engineers were the highest, suggesting
that clean process engineers are exposed to arsenic. Fur-
ther studies to evaluate occupational arsenic exposure in
semiconductor manufacturing, especially in clean process
engineers, are warranted.Competing interest
The authors do not have any competing interests issues in this study.Authors’ contributions
KWB analyzed the data and described the whole paper. YLW and HSI
analyzed the metabolites of arsenics. YIH and DHK analyzed the data and
participated all the discussion. EAK organized this study, analyzed the data
and discussed all the results. All authors read and approved the final
manuscript.
Author details
1Occupational Safety and Health Research Institute, Korea Occupational
Safety and Health Agency, Munemi-ro 478 Gusan-dong, Incheon-city
430-711, Republic of Korea. 2Neodin Medical Institute, Seoul, South Korea.
Received: 25 June 2013 Accepted: 3 September 2013
Published: 11 October 2013References
1. Park SH, Shin JA, Park HD: Exposure Possibility to By-products during the
Processes of Semiconductor Manufacture. J Korean Soc Occup Environ Hyg
2012, 22:52–59.
2. Hwang YH, Chen SC: Monitoring of low level arsenic exposure during
maintenance of ion implanters. Arch Environ Health 2000, 55:347–354.
3. Ungers LJ, Jones JH, McIntyre AJ, McHenry CR: Release of arsenic from
semiconductor wafers. Am Ind Hyg Assoc J 1985, 46:416–420.
4. Park DU, Yang HS, Jeong JY, Ha KC, Choi SJ, Kim CN, Yoon CS, Park DY,
Paek DM: A comprehensive review of arsenic levels in the semiconductor
manufacturing industry. Ann Occup Hyg 2010, 54:869–879.
5. LaDou J: CURRENT Occupational & Environmental Medicine: Fourth Edition.
McGraw-Hill Education; 2007.
6. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F,
Bouvard V, Guha N, Freeman C, Galichet L, Cogliano V: A review of human
carcinogens¡ªPart C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009,
10:453–454.
7. Tseng C-H: Arsenic methylation, urinary arsenic metabolites and human
diseases: current perspective. Environ Carcinog Ecotoxicol Rev 2007, 25:1–22.
8. Tseng C-H: A review on environmental factors regulating arsenic
methylation in humans. Toxicol Appl Pharmacol 2009, 235:338–350.
9. ACGIH: Documentations of the Threshold Limit Values and Biological Exposure
Indices. Cincinnati (OH); 2010.
10. Marafante E, Vahter M, Dencker L: Metabolism of arsenocholine in mice,
rats and rabbits. Sci Total Environ 1984, 34:223–240.
11. Vahter M, Marafante E, Dencker L: Metabolism of arsenobetaine in mice,
rats and rabbits. Sci Total Environ 1983, 30:197–211.
12. Buchet JP, Lauwerys R, Roels H: Comparison of several methods for the
determination of arsenic compounds in water and in urine. Their
application for the study of arsenic metabolism and for the monitoring of
workers exposed to arsenic. Int Arch Occup Environ Health 1980, 46:11–29.
13. Offergelt JA, Roels H, Buchet JP, Boeckx M, Lauwerys R: Relation between
airborne arsenic trioxide and urinary excretion of inorganic arsenic and
its methylated metabolites. Br J Ind Med 1992, 49:387–393.
14. Park HH, Jang JK, Shin JA: Quantitative exposure assessment of various
chemical substances in a wafer fabrication industry facility. Saf Health
Work 2011, 2:39–51.
Byun et al. Annals of Occupational and Environmental Medicine 2013, 25:21 Page 8 of 8
http://www.aoemj.com/content/25/1/2115. Farmer JG, Johnson LR: Assessment of occupational exposure to
inorganic arsenic based on urinary concentrations and speciation of
arsenic. Br J Ind Med 1990, 47:342–348.
16. Morton J, Mason H: Speciation of Arsenic Compounds in Urine from
Occupationally Unexposed and Exposed Persons in the U.K. Using a
Routine LC-ICP-MS Method. J Anal Toxicol 2006, 30:293–301.
17. Hwang Y-H, Lee Z-Y, Wang J-D, Hsueh Y-M, Lu IC, Yao W-L: Monitoring of
arsenic exposure with speciated urinary inorganic arsenic metabolites
for ion implanter maintenance engineers. Environ Res 2002, 90:207–216.
18. De Peyster A, Silvers JA: Arsenic levels in hair of workers in a
semiconductor fabrication facility. Am Ind Hyg Assoc J 1995, 56:377–383.
19. Hu CW, Pan CH, Huang YL, Wu MT, Chang LW, Wang CJ, Chao MR: Effects
of arsenic exposure among semiconductor workers: a cautionary note
on urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine. Free Radic Biol Med 2006,
40:1273–1278.
20. Physical examination health diagnosis practices. vol 1: Outline of specific
medical examination. Incheon: Korean Occupational Safety & Health Agency;
2012.
21. FAO Statistical Database, Food balance sheets. http://faostat.fao.org/site/368/
default.aspx#ancor.
22. Hata A, Endo Y, Nakajima Y, Ikebe M, Ogawa M, Fujitani N, Endo G:
HPLC-ICP-MS speciation analysis of arsenic in urine of Japanese subjects
without occupational exposure. J Occup Health 2007, 49:217–223.
23. Hsueh Y, Hsu M, Chiou H, Yang M, Huang C, Chen C: Urinary arsenic
speciation in subjects with or without restriction from seafood dietary
intake. Toxicol Lett 2002, 133:83–91.
24. Kim YH, Lee BK: Association between urinary arsenic and diabetes
mellitus in the Korean general population according to KNHANES 2008.
Sci Total Environ 2011, 409:4054–4062.
25. Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP: Evaluation of
DNA damage in patients with arsenic poisoning: urinary 8-
hydroxydeoxyguanine. Toxicol Appl Pharmacol 2004, 198:291–296.
26. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD: Levels
of urinary total and speciated arsenic in the US population: National
Health and Nutrition Examination Survey 2003–2004. J Expo Sci Environ
Epidemiol 2009, 19:59–68.
27. Buchet JP, Pauwels J, Lauwerys R: Assessment of exposure to inorganic
arsenic following ingestion of marine organisms by volunteers.
Environ Res 1994, 66:44–51.
28. Ma M, Le XC: Effect of arsenosugar ingestion on urinary arsenic
speciation. Clin Chem 1998, 44:539–550.
29. Choi BS, Choi SJ, Kim DW, Huang M, Kim NY, Park KS, Kim CY, Lee HM,
Yum YN, Han ES, et al: Effects of Repeated Seafood Consumption on
Urinary Excretion of Arsenic Species by Volunteers. Arch Environ Contam
Toxicol 2010, 58:222–229.
30. Hakala E, Pyy L: Assessment of exposure to inorganic arsenic by
determining the arsenic species excreted in urine. Toxicol Lett 1995,
77:249–258.
doi:10.1186/2052-4374-25-21
Cite this article as: Byun et al.: Assessment of Arsenic Exposure by
Measurement of Urinary Speciated Inorganic Arsenic Metabolites in
Workers in a Semiconductor Manufacturing Plant. Annals of Occupational
and Environmental Medicine 2013 25:21.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
